Polypill for prevention of cardiovascular diseases with focus on non-alcoholic steatohepatitis: the PolyIran-Liver trial

Individuals with non-alcoholic steatohepatitis or elevated liver enzymes have increased cardiovascular mortality but are often excluded from prevention trials. We investigated the effectiveness of fixed-dose combination therapy for the prevention of major cardiovascular events (MCVE) among individua...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2022-06, Vol.43 (21), p.2023-2033
Hauptverfasser: Merat, Shahin, Jafari, Elham, Radmard, Amir Reza, Khoshnia, Masoud, Sharafkhah, Maryam, Nateghi Baygi, Alireza, Marshall, Tom, Shiravi Khuzani, Abolfazl, Cheng, Kar Keung, Poustchi, Hossein, Malekzadeh, Reza
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!